LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 831

Search options

  1. Article ; Online: Diagnostic challenges and updated therapeutic strategies of Kimura's disease: A case report successfully treated by dupilumab and review.

    Cordeil, Stephanie / Hermine, Olivier / Hot, Arnaud

    Medicine

    2023  Volume 102, Issue 47, Page(s) e34191

    Abstract: Rationale: Kimura's disease (KD) is a rare and chronic eosinophilic related-disease, characterized by subcutaneous tissue masses, regional enlarged lymph nodes, hypereosinophilia and elevated serum IgE. KD usually affects young adults in the Asian ... ...

    Abstract Rationale: Kimura's disease (KD) is a rare and chronic eosinophilic related-disease, characterized by subcutaneous tissue masses, regional enlarged lymph nodes, hypereosinophilia and elevated serum IgE. KD usually affects young adults in the Asian population. In Western countries, the clinical and biological presentation of KD is often unknown, delaying the diagnosis. Therapeutic management is not standardized and despite recent advances, remission from KD can be difficult to achieve, especially in relapse situations.
    Patient concerns: We report the case of an non-Asian man with KD, initially misdiagnosed as lymphoma. We focus on his long-lasting clinical course with 20 years of recurrence despite several therapeutic lines.
    Diagnoses and interventions: We have emphasized the key points of the KD diagnostic challenge. We chose to focus on hemopathies as diagnostic traps to illustrate several overlapping features that blur frontiers with KD. With regard to treatments, lessons can be learned from the use of the therapeutic backbone, which relies on excision surgery, radiotherapy and corticosteroids.
    Outcomes: Advancements in KD pathogenesis have highlighted the pivotal role of Th2 lymphocytes driving eosinophil activation. Directly inspired by eosinophilic and allergic field practices, targeted therapies, such as dupilumab, provide hope for potential curative options.
    Lessons: Finally, we propose a therapeutic plan to treat newly diagnosed KD and discuss options for relapsing entities.
    MeSH term(s) Male ; Young Adult ; Humans ; Angiolymphoid Hyperplasia with Eosinophilia/diagnosis ; Angiolymphoid Hyperplasia with Eosinophilia/drug therapy ; Angiolymphoid Hyperplasia with Eosinophilia/pathology ; Kimura Disease/pathology ; Lymph Nodes/pathology ; Adrenal Cortex Hormones/therapeutic use
    Chemical Substances dupilumab (420K487FSG) ; Adrenal Cortex Hormones
    Language English
    Publishing date 2023-11-25
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000034191
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Comment on Kieslinger et al. A Recurrent

    Freiche, Valérie / Couronné, Lucile / Bruneau, Julie / Hermine, Olivier

    Cancers

    2022  Volume 14, Issue 19

    Abstract: We have read with great interest the recently published article by M. Kieslinger et al. in Cancers Journal [ ... ]. ...

    Abstract We have read with great interest the recently published article by M. Kieslinger et al. in Cancers Journal [...].
    Language English
    Publishing date 2022-09-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14194593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder.

    Isnard, Pierre / Huynh, Tony / Lhermitte, Ludovic / Hermine, Olivier / Thervet, Eric / Molina, Thierry Jo

    Kidney international reports

    2023  Volume 9, Issue 3, Page(s) 725–729

    Language English
    Publishing date 2023-12-29
    Publishing country United States
    Document type Case Reports
    ISSN 2468-0249
    ISSN (online) 2468-0249
    DOI 10.1016/j.ekir.2023.12.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study.

    Rossignol, Julien / Hatton, Séverine / Ridley, Ashley / Hermine, Olivier / Greco, Céline

    Biomedicines

    2023  Volume 11, Issue 2

    Abstract: Mastocytosis patients often experience a number of symptoms, including mastocytosis-associated pain that is difficult to manage due to resistance to usual antalgic treatments and/or the patient's poor tolerance. Mastocytosis patients display ... ...

    Abstract Mastocytosis patients often experience a number of symptoms, including mastocytosis-associated pain that is difficult to manage due to resistance to usual antalgic treatments and/or the patient's poor tolerance. Mastocytosis patients display significantly higher levels of indoleamine-2,3-dioxygenase-1 (IDO1) activity, leading to hyperactivation of the N-methyl-D-aspartate receptor. As cannabidiol (CBD) is known to inhibit IDO1's enzymatic activity, we hypothesized that pharmaceutical-grade CBD is an effective treatment for mastocytosis-associated pain. Patients with non-advanced mastocytosis and refractory pain were eligible for inclusion in this observational pilot study. CBD was initiated at 50 mg/day and increased to a maximum of 900 mg/day. Pain was scored on a 0-to-10 numerical rating scale (NRS). A total of 44 patients were included over a 2-year period. The median dose of CBD prescribed was 300 mg/day (range: 50-900 mg/day). Elevated liver enzymes were observed in one patient. The mean ± standard deviation NRS pain score decreased significantly from 7.27 ± 1.35 before treatment to 3.78 ± 1.99 after 3 months of treatment (
    Language English
    Publishing date 2023-02-10
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11020520
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: ATL treatment: is it time to change?

    Hermine, Olivier

    Blood

    2015  Volume 126, Issue 24, Page(s) 2533–2534

    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Hematopoietic Stem Cell Transplantation/statistics & numerical data ; Humans ; Leukemia-Lymphoma, Adult T-Cell/therapy ; Male
    Language English
    Publishing date 2015-12-03
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2015-10-670489
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Successful Rezafungin Treatment of an Azole-Resistant Chronic Mucocutaneous Candidiasis in a STAT-1 Gain-of-Function Patient.

    Melenotte, Cléa / Ratiney, Robert / Hermine, Olivier / Bougnoux, Marie-Elisabeth / Lanternier, Fanny

    Journal of clinical immunology

    2023  Volume 43, Issue 6, Page(s) 1182–1184

    MeSH term(s) Humans ; Azoles/pharmacology ; Azoles/therapeutic use ; Candidiasis, Chronic Mucocutaneous/drug therapy ; Candidiasis, Chronic Mucocutaneous/genetics ; Gain of Function Mutation ; Echinocandins ; Antifungal Agents/therapeutic use
    Chemical Substances Rezafungin (G013B5478J) ; Azoles ; Echinocandins ; Antifungal Agents
    Language English
    Publishing date 2023-05-29
    Publishing country Netherlands
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-023-01519-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance.

    Puszko, Anna K / Sosnowski, Piotr / Hermine, Olivier / Hopfgartner, Gérard / Lepelletier, Yves / Misicka, Aleksandra

    Bioorganic & medicinal chemistry

    2023  Volume 94, Page(s) 117482

    Abstract: Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF- ... ...

    Abstract Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF-A
    Language English
    Publishing date 2023-09-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2023.117482
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Tocilizumab in Coronavirus Disease 2019: Give It Time!

    Richier, Quentin / Plaçais, Léo / Lacombe, Karine / Hermine, Olivier

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2021  Volume 73, Issue 12, Page(s) 2368–2369

    MeSH term(s) Antibodies, Monoclonal, Humanized ; COVID-19/drug therapy ; Humans ; SARS-CoV-2
    Chemical Substances Antibodies, Monoclonal, Humanized ; tocilizumab (I031V2H011)
    Language English
    Publishing date 2021-01-29
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciab081
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Tocilizumab in Treatment for Patients With COVID-19-Reply.

    Hermine, Olivier / Mariette, Xavier / Ravaud, Philippe

    JAMA internal medicine

    2020  Volume 181, Issue 7, Page(s) 1020–1021

    Language English
    Publishing date 2020-12-01
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2699338-7
    ISSN 2168-6114 ; 2168-6106
    ISSN (online) 2168-6114
    ISSN 2168-6106
    DOI 10.1001/jamainternmed.2021.0407
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Exchange of subtelomeric regions between chromosomes 4q and 10q reverts the FSHD genotype and phenotype.

    Ma, Yinxing / Schwager Karpukhina, Anna / Dib, Carla / Gautier, Candice / Hermine, Olivier / Allemand, Eric / Vassetzky, Yegor S

    Science advances

    2024  Volume 10, Issue 18, Page(s) eadl1922

    Abstract: The most common form of facioscapulohumeral dystrophy (FSHD1) is caused by a partial loss of the D4Z4 macrosatellite repeat array in the subtelomeric region of chromosome 4. Patients with FSHD1 typically carry 1 to 10 D4Z4 repeats, whereas nonaffected ... ...

    Abstract The most common form of facioscapulohumeral dystrophy (FSHD1) is caused by a partial loss of the D4Z4 macrosatellite repeat array in the subtelomeric region of chromosome 4. Patients with FSHD1 typically carry 1 to 10 D4Z4 repeats, whereas nonaffected individuals have 11 to 150 repeats. The ~150-kilobyte subtelomeric region of the chromosome 10q exhibits a ~99% sequence identity to the 4q, including the D4Z4 array. Nevertheless, contractions of the chr10 array do not cause FSHD or any known disease, as in most people D4Z4 array on chr10 is flanked by the nonfunctional polyadenylation signal, not permitting the DUX4 expression. Here, we attempted to correct the FSHD genotype by a CRISPR-Cas9-induced exchange of the chr4 and chr10 subtelomeric regions. We demonstrated that the induced t(4;10) translocation can generate recombinant genotypes translated into improved FSHD phenotype. FSHD myoblasts with the t(4;10) exhibited reduced expression of the DUX4 targets, restored PAX7 target expression, reduced sensitivity to oxidative stress, and improved differentiation capacity.
    MeSH term(s) Muscular Dystrophy, Facioscapulohumeral/genetics ; Humans ; Chromosomes, Human, Pair 4/genetics ; Phenotype ; Genotype ; Telomere/genetics ; Telomere/metabolism ; Chromosomes, Human, Pair 10/genetics ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Translocation, Genetic ; PAX7 Transcription Factor/genetics ; PAX7 Transcription Factor/metabolism ; CRISPR-Cas Systems ; Myoblasts/metabolism
    Chemical Substances Homeodomain Proteins ; DUX4L1 protein, human ; PAX7 Transcription Factor ; PAX7 protein, human
    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.adl1922
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top